Orlistat is a fatty acid synthase (FASN) inhibitor caused the modulation of AMPK and lipogenesis signaling axis in PC3 prostate cancer cells but not in PNT1A prostate epithelial cells

Nebiler, E.Adacan, K.Çoker Gürkan, AjdaPalavan Ünsal, Zeynep NarçınARISAN, ELİF DAMLAYERLİKAYA, PINAR OBAKAN2018-07-202018-07-202017-091742-464X1742-4658https://hdl.handle.net/11413/2230en-USOrlistat is a fatty acid synthase (FASN) inhibitor caused the modulation of AMPK and lipogenesis signaling axis in PC3 prostate cancer cells but not in PNT1A prostate epithelial cellsArticle409918904190409918904190